CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry) Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology/American Heart Association Guidelines for Management of Valvular Heart Disease Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization Association of Smoking Status With Long‐Term Mortality and Health Status After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement

Original Research2022 Mar 9;100193.

JOURNAL:J Lipid Res. Article Link

Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses

D Ibi, M Boot, MET Dollé et al.

Full Text PDF